GIS vs INSM · P/E 8.2, rev $18.42B vs rev $731.5M
General Mills Inc (GIS) versus Insmed Inc (INSM) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Insmed Inc (INSM) is a biotechnology company listed on US.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported INSM revenue for 2026-06-30 was $731.5M. Net income was -$176.8M. INSM currently screens at market cap $20.42B.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. INSM currently screens at market cap $20.42B.
Not investment advice. Open the GIS and INSM stock pages for the full models.
Not investment advice.